Thermo Fisher Scientific (TMO) Announces Senior Note Offering
Tweet
Share
E-mailGet Alerts TMO Hot Sheet
Join SI Premium – FREE
Thermo Fisher Scientific Inc. (NYSE: TMO) announced today that it intends to offer senior notes to fund its acquisition of Phadia.
The aggregate purchase price of this transaction is estimated to be €2.47 billion (approximately $3.5 billion). The Phadia acquisition was announced by the company on May 19, 2011.
The aggregate purchase price of this transaction is estimated to be €2.47 billion (approximately $3.5 billion). The Phadia acquisition was announced by the company on May 19, 2011.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Thermo Fisher Scientific (TMO) call put ratio 4.8 calls to 1 put with a focus on March 700 calls as share price up 4.2%
- Denarius Metals acquires 15% stake in Copper Giant, Trafigura invests
- WhiteFiber closes $310M convertible notes offering at 5% due 2032
Create E-mail Alert Related Categories
Equity OfferingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
